Radwan Alkhatib

Radwan Alkhatib

Auto-generated profile, based on publicly available information

Radwan Alkhatib

Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2024 in JCO Global Oncology
Verified
Journal Article
Open access
SBShouki Bazarbashi
Shouki Bazarbashi
RARadwan Alkhatib
Radwan Alkhatib
MAMohamed Aseafan
Mohamed Aseafan
YTYasmin Tuleimat
Yasmin Tuleimat
NANashwa Abdel-Aziz
Nashwa Abdel-Aziz
MAMohammed Alghamdi
Mohammed Alghamdi
PURPOSE: Metastatic colorectal cancer (mCRC) is a significant global health burden. This retrospective study compared the effectiveness of trifluridine/tipiracil (FTD/TPI), regorafenib, and chemotherapy rechallenge for third-line mCRC treatment. MATERIALS AND METHODS: We reviewed the medical records of 132 patients with mCRC treated with regorafenib, FTD/TPI, or a rechallenge with the initial chemotherapy regimen in a third-line setting from four different institutions. The primary end point was progression-free survival (PFS). Secondary end points were objective response rate and overall survival (OS) across the three treatment approaches. RESULTS: Twenty-nine patients received chemotherapy rechallenge, and 103 received FTD/TPI or regorafenib. Patients' characteristics were comparable, except for a lower number of left-sided primaries and KRAS wild-type tumors in the FTD/TPI-regorafenib group. The median PFS for the entire group was 3.0 months, and the median OS was 13.7 months. Chemotherapy rechallenge has resulted in a median PFS of 3.1 months and a median OS of 21.2 months, compared with 2.9 months (PFS) and 12.6 months (OS) for the FTD/TPI-regorafenib group. Multivariate analyses identified male sex and an Eastern Cooperative Oncology Group performance status (ECOG PS) of 0-1 as independent prognostic factors for better PFS, whereas chemotherapy rechallenge, localized stage at diagnosis, and an ECOG PS of 0-1 were significant prognostic factors for better OS. CONCLUSION: This study suggests that chemotherapy rechallenge may provide a survival benefit in the third-line treatment of mCRC. However, patient characteristics, such as sex and ECOG PS, should also be considered in treatment decisions. Further prospective studies are required to confirm our findings.

1 May 2024 in Advances in Medical Education and Practice
Verified
Journal Article
Open access
PDF file
MMMohammed Al Mairi
Mohammed Al Mairi
YYYasmin Youssef
Yasmin Youssef
AAAhmad Alhamshari
Ahmad Alhamshari
RARadwan Alkhatib
Radwan Alkhatib
HKHamzah Koujan
Hamzah Koujan
ASAniko Szabo
Aniko Szabo
Objective: To assess the perception of medical students at Alfaisal University College of Medicine (AUCOM) of their learning environment at a referral-based tertiary hospital in Riyadh, Saudi Arabia. Methods: The validated Dundee Ready Educational Environment Measure (DREEM) questionnaire was administered to all year 4 and year 5 students during the academic year 2020– 2021. Scores were analyzed using the descriptors provided by the questionnaire developers and compared across different students’ cohorts using SPSS. Results: The overall DREEM score was 120.45/200, which can be described as a “more positive than negative environment”, indicating a positive perception with a potential for improvement. All domain scores were on the positive side except the “students’ social self-perception” which had a score indicating a problematic area. Female students had a statistically significant more positive score in the domain “students’ perception of learning” than male students. Scores for individual questions were persistently on the positive side except for eight questions that pointed to problematic areas in the curriculum. When compared between student cohorts, five questions had statistically significant difference in scores between students in both academic years, but only two of those had scores indicating concerning areas. Conclusion: Referral-based tertiary hospitals can be perceived positively by students as a learning environment in undergraduate medical education. We identified some areas of concern in our curriculum to be targeted by future research.

30 October 2025 in Structural Heart
Verified
Journal Article
Open access
FMFaysal Massad
Faysal Massad
OBOsamah Badwan
Osamah Badwan
ARAkiva Rosenzveig
Akiva Rosenzveig
FZFawzi Zghyer
Fawzi Zghyer
ZSZaid Shahrori
Zaid Shahrori
SKSamir Kapadia
Samir Kapadia
• First study to assess finerenone in valve replacement patients. • Finerenone linked to fewer heart failure events after valve replacement. • Long-term outcomes similar between finerenone and other MRAs.

18 June 2026 in JACC: Case Reports
Verified
Journal Article
Open access
RARadwan Alkhatib
Radwan Alkhatib
FZFawzi Zghyer
Fawzi Zghyer
THTaha Hatab
Taha Hatab
CTChadi Tabaja
Chadi Tabaja
FMFaysal Massad
Faysal Massad
KZKhaled M. Ziada
Khaled M. Ziada
Severe pectus excavatum is an uncommon cause of hemodynamic compromise in adults and may present with unexplained tachycardia when preload filling is impaired by cardiac compression. A 65-year-old woman with long-standing palpitations presented with sinus tachycardia despite high-dose beta-blockade. Electrocardiogram and ambulatory monitoring showed sinus rhythm with marked heart rate variability. Right heart catheterization revealed low filling pressures, with a mean right atrial pressure of 1 mm Hg and preserved cardiac output. Cardiovascular magnetic resonance showed severe pectus excavatum (Haller index: 8.1) with anterior cardiac compression. Pectus-induced preload insufficiency was deemed responsible for her symptoms. She underwent a modified Ravitch repair with complete resolution of palpitations and normalization of heart rate. Chest wall deformity can cause clinically significant cardiac compression, preload insufficiency, and compensatory sinus tachycardia, even in late adulthood. Severe pectus excavatum should be recognized as a reversible cause of preload insufficiency and sinus tachycardia, and surgical correction may result in symptom resolution.

1 August 2023 in Cureus
Verified
Journal Article
Open access
PDF file
EHEmaan Haque
Emaan Haque
AMAli Mushtaq
Ali Mushtaq
RARadwan Alkhatib
Radwan Alkhatib
HAHamed Alhusaini
Hamed Alhusaini
KSKausar Suleman
Kausar Suleman
Background: Breast cancer survival rates are increasing more than ever with the development of better diagnostic and therapeutic techniques. Survivors of breast cancer have an increased risk of developing second primary malignancies, which may be mistaken for breast cancer recurrence and lead to delayed diagnosis and poor prognosis. Case report: We report a case of a 62-year-old female who presented with shortness of breath and bone pain. She had a history of left triple-positive invasive ductal carcinoma (T1N0M0) treated with bilateral skin-sparing mastectomy, adjuvant Taxotere, and trastuzumab-based therapy and then continued on trastuzumab and letrozole. She underwent imaging to explore the source of her symptoms at which new pulmonary nodules were discovered. During workup, she was found to have elevated tumor markers. They were initially suspected to be breast cancer recurrence metastases based on elevated tumor markers; however, further investigations confirmed that the nodules were a second primary lung adenocarcinoma with a different molecular profile. The patient had disease progression despite chemotherapy and eventually succumbed to her disease. Conclusion: This case highlights the importance of considering second primary malignancies in breast cancer survivors and utilizing advanced diagnostic modalities to efficiently diagnose such cases.

2 April 2026 in European Heart Journal - Valvular and Structural Heart Disease
Verified
Journal Article
Open access
PDF file
RARadwan Alkhatib
Radwan Alkhatib
THTaha Hatab
Taha Hatab
OBOsamah Badwan
Osamah Badwan
MKMangesh Kritya
Mangesh Kritya
ARAkiva Rosenzveig
Akiva Rosenzveig
SKSamir R Kapadia
Samir R Kapadia
Background and aims: Severe tricuspid regurgitation (TR) is associated with substantial morbidity, mortality, and impaired quality of life. Transcatheter tricuspid edge-to-edge repair (T-TEER) and transcatheter tricuspid valve replacement (TTVR) have emerged as treatment options, but comparative evidence to guide procedural selection remains limited. To systematically evaluate the safety and clinical outcomes of T-TEER and TTVR in patients with severe TR. Methods and results: A systematic review and meta-analysis were performed according to PRISMA guidelines, including studies published through July 2025. Random-effects models were used to pool outcomes at in-hospital, 30-day, and 1-year follow-up. Twenty studies comprising 4468 patients undergoing T-TEER and 20 studies including 1017 patients undergoing TTVR were included. T-TEER was associated with very low in-hospital (0.13%) and 30-day (0.46%) mortality, with 1-year mortality of 10.16%. Early mortality was high following TTVR, whereas 1-year mortality was similar between strategies. TTVR achieved more complete and durable elimination of severe TR, while T-TEER resulted in meaningful but less complete TR reduction. Both approaches were associated with substantial improvements in New York Heart Association functional class and quality of life. TTVR was associated with higher rates of permanent pacemaker implantation, thrombotic events, and major bleeding that increased over time, whereas bleeding after T-TEER was predominantly peri-procedural. Changes in right ventricular systolic function were modest and similar between approaches. Conclusion: T-TEER and TTVR are associated with improvements in clinical and echocardiographic outcomes in patients with severe TR. These findings are descriptive and hypothesis-generating, highlighting the need for prospective studies to clarify optimal patient selection and long-term outcomes.